Search Results 381-390 of 2818 for 搜索引擎入口咨询邮箱：lgooxc@hotmail.com

  1. Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papillomavirus-Related Cancer in Adult Women After Kidney Transplant - Mayo Clinic

    About this study. This trial studies whether the nonavalent human papillomavirus vaccine given to adult women prior to kidney transplantation can help the ...

  2. Collaborators - Neurogenesis and Brain Tumors: Hugo Guerrero Cazares - Mayo Clinic Research

    Research collaborators of Dr. Guerrero Cazares' Neurogenesis and Brain Tumors Lab at Mayo Clinic's campus in Florida.

  3. Faculty - Center for Individualized Medicine - Mayo Clinic Research

    O'Sullivan, Ciara M.B., B.Ch. osullivan.ciara@mayo.edu; Associate Professor of Oncology. More about research at Mayo Clinic.

  4. Collaborators - Genomic and Exposomic Hepatobiology: Konstantinos N. Lazaridis - Mayo Clinic Research

    Collaborators. Dr. Lazaridis is involved in several research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators.

  5. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...

  6. Contact - Hormones and Cancer Laboratory - Mayo Clinic Research

    Contact Dr. Thompson about his research on RNA sequence analysis for breast cancer and HER2-targeted therapy in his Hormones and Cancer Lab at Mayo Clinic.

  7. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (enrollment by invitation only) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to the normalization of temperature and oxygen saturation ...

  8. EEG Cap for Identification of Non-Convulsive Status Epilepticus - Mayo Clinic

    NCSE becomes more refractory to treatment after one hour of seizure activity, making rapid identification and treatment of NCSE of great clinical importance.

  9. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.

  10. SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) - Mayo Clinic

    The study will involve administering the study drug as a single dose of study drug or placebo. This study is designed to demonstrate the superiority of the ...